BNET Industries

Alpharma Inc.

(ALO) is in the Pharma Industry

Last Fiscal Year Sales:$722.4M
  • Public
  • US
Dow Jones Description

Specialty Generic & Proprietary Human Pharmaceuticals & Animal Health Products Developer, Mfr & Marketer

President & Chief Executive Officer
Dean J. Mitchell
Number of Employees 2,000
Contact Information

440 Route 22 East

Bridgewater, New Jersey 08807

alpharmaequine....

(908) 566-3800

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • The Real King of the Drug Pushers

    8/14/09 - Merger / Acquisition - View Story

News & Analysis

alpharma inc. - All News and Analysis

  • Alpharma, Inc. Q2 2008 Earnings Call Transcript

    Seeking Alpha - 2008-07-30

    Question-and-Answer SessionOperator Operator Instructions. Our first question comes from Gregg Gilbert with Merrill Lynch. Gregg Gilbert - Merrill Lynch Good morning. Dean and Jeff, hopefully you can provide some color, if not the specifics around your new outlook for Animal Health sales and margins for '08 and longer term...

    Tags: Alpharma Inc.

  • Alpharma, Inc. Q1 2008 Earnings Call Transcript

    Seeking Alpha - 2008-05-05

    Question-and-Answer SessionOperator Thank you very much. Operator Instructions. Our first question will from Gregg Gilbert, Merrill Lynch. Gregg Gilbert - Merrill Lynch Thanks, good morning. Starting with EMBEDA, Dean, can you provide more specific color on the technical issues around the data presentation that delayed the NDA? And secondly,...

    Tags: Alpharma Inc.

  • Alpharma to Present at Morgan Stanley Global Healthcare Unplugged Conference

    - 2008-04-25

    Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, announced today that senior management will provide an overview of the company's business at the Morgan Stanley Global Healthcare Unplugged Conference on Friday, May 2, 2008 at 10:30AM Eastern Daylight Time. The conference will be held at The Ritz...

    Tags: Alpharma Inc., conference, Morgan Stanley

  • Alpharma Inc. 2008 Financial Outlook Call Transcript

    Seeking Alpha - 2008-04-14

    Question-and-Answer SessionOperator Your first question comes from Gregg Gilbert - Merrill Lynch Gregg Gilbert – Merrill Lynch First for Jeff, is there any significant lumpiness by quarter in SG&A or R&D that’s worth calling out or should those lines build pretty consistently over the course of the year? Jeff...

    Tags: Alpharma Inc.

  • Alpharma Inc. Q4 2007 Earnings Call Transcript

    Seeking Alpha - 2008-03-10

    Question-and-Answer Session Operator Operator Instructions. Our first question today comes from Greg Gilbert - Merrill Lynch. Greg Gilbert - Merrill Lynch I have a couple. First some housekeep stuff for Jeff. I was hoping you could provide actuals or estimates for gross margin for API for the...

    Tags: Alpharma Inc.

Decision Makers

Name (plus bio) Position
Dean J. Mitchell President & Chief Executive Officer
Carl-Ake Carlsson President, API
Carol Wrenn President, Animal Health
Jeffrey S. Campbell Interim Chief Financial Officer
Matthew T. Farrell CFO & Executive Vice President
Richard J. Cella Chief Information Officer
Robert Wrobel Clo
Ronald N. Warner Executive Vice President & Chief Scientific Officer
Thomas J. Spellman Chief Legal Officer, Secretary & Executive Vice President
Peter Watts Executive Vice President, HR & Comm
Stefan Aigner Executive Vice President, Corporate and Business Development
R. Scott Shively Senior Vice President, Pharmaceutical Commercial Operations
Scott Shively Senior Vice President, Sales & Marketing
David Whitehead Vice President, Sales
John F. Konzelmann Vice President
Charlie Choi Marketing Dept Manager
Farah M. Walters Director

Board of Directors

Name (plus bio) Position
Finn Berg Jacobsen Audit Committee Chairman
Peter G. Tombros Chairman
Ramon M. Perez Chairman, Compensation Committee
William I. Jacobs Audit & Corporate Governance Committee Chairman
David C. U'Prichard Board of Directors
Einar W. Sissener Board of Directors
Peter W. Ladell Board of Directors
Robert Thong Board of Directors

Organization Position Status
Alpharma, Inc. President & Chief Executive Officer Current
Intrexon Corp Board Member Current
Alpharma, Inc. Board of Directors Current
National Pharmaceutical Council Board of Directors Current
ISTA Pharmaceuticals, Inc. Board of Directors Current
Guilford Pharmaceuticals, Inc. Chief Executive Officer Former
Guilford Pharmaceuticals, Inc. President Former
Bristol-Myers Squibb Company President, International Former
GlaxoSmithKline Plc Senior Vice President, Clinical Development & Product Strategy Former
GlaxoSmithKline Plc Vice President & General Manager, Specialty Divisions, Strategic Planning and Business Development Former
Bristol-Myers Squibb Company Vice President Former
MGI PHARMA Inc. Board of Directors Current
City University London MBA Former

Organization Position Status
Alpharma, Inc. President, API Current
Alpharma, Inc. President, API & Executive Vice President Former

Organization Position Status
Alpharma, Inc. President, Animal Health Current
Alpharma, Inc. President, Animal Health & Executive Vice President Former
Honeywell International Inc. Managing Director, European Operations Former
Honeywell International Inc. Business Director, Fluorine Products Division Former
Honeywell International Inc. Executive Positions Former

Organization Position Status
Alpharma, Inc. Interim Chief Financial Officer Current
Alpharma, Inc. Vice President, Finance Current
Ingersoll-Rand Company Limited Assistant Corporate Controller Former
Alpharma, Inc. Controller Former
Alpharma, Inc. Board of Directors Former

Organization Position Status
Alpharma, Inc. CFO & Executive Vice President Current
Alpharma, Inc. Board of Directors Current

Organization Position Status
Alpharma, Inc. Chief Information Officer Current
Executive Order, Inc. Executive Vice President and CIO Current
Executive Order, Inc. Board of Directors Current
Alpharma, Inc. Executive Vice President Former

Organization Position Status
Alpharma, Inc. Clo Current
Alpharma, Inc. Secretary Current
Marley & Company, Inc Chief Administrative Officer Former
Marley & Company, Inc Senior Vice President Former
Duracell Vice President Former
Alpharma, Inc. Vice President & Secretary Former
Duracell Associate General Counsel Former
Marley & Company, Inc General Counsel Former

Organization Position Status
Alpharma, Inc. Executive Vice President & Chief Scientific Officer Current
Alpharma, Inc. President, Branded Products Former
Alpharma, Inc. President, Pharmaceuticals & Executive Vice President Former

Organization Position Status
Alpharma, Inc. Chief Legal Officer, Secretary & Executive Vice President Current

Organization Position Status
Alpharma, Inc. Executive Vice President, HR & Comm Current

Dr. Aigner has more than 20 years of experience in the global healthcare industry. He is currently the EVP, Corporate and Business Development for Alpharma, Inc. (NYSE: ALO), a leading global specialty pharmaceutical company. Before joining Alpharma, Dr. Aigner was co-founder and Executive Vice President of Business Development for Reliant Pharmaceuticals, Inc., a pharmaceutical company that specializes in the development, commercialization and marketing of prescription therapeutic products. During his tenure with Reliant, Dr. Aigner led the company through multiple product acquisitions and significant in-licensing transactions and was responsible for building the company's cardiovascular portfolio through strong partnerships with leading U.S. and European companies. Prior to Reliant, Dr. Aigner was a consultant with leading healthcare consulting firm The Wilkerson Group, where he focused on development of corporate strategies, assessment of new products, and evaluation of potential partnering candidates.

Organization Position Status
Alpharma, Inc. Executive Vice President, Corporate and Business Development Current
Cipher Pharmaceuticals Inc. Board of Directors Current
Reliant Pharmaceuticals, Inc. Executive Vice President of Business Development Former
Alpharma, Inc. Co-Founder Reliant Pharmaceuticals Former
Reliant Pharmaceuticals, Inc. Co-Founder Former
The Wilkerson Group Consultant Former

Organization Position Status
Alpharma, Inc. Senior Vice President, Pharmaceutical Commercial Operations Current

Organization Position Status
Alpharma, Inc. Senior Vice President, Sales & Marketing Current

Organization Position Status
Alpharma, Inc. Vice President, Sales Current

Organization Position Status
Alpharma, Inc. Vice President Current
Alpharma, Inc. Controller Current
Alpharma, Inc. Principal Accounting Officer Former

Organization Position Status
Alpharma, Inc. Marketing Dept Manager Current

Organization Position Status
Alpharma, Inc. Audit Committee Chairman Current
Alpharma, Inc. Director Former

Peter Tombros has served as a Board Director since 1998 and in January 2008 was appointed Chairman. Previously, he served as Lead Director since May 2006. Since 2005, Mr. Tombros has served as Professor and executive in residence in the Eberly College of Science B.S./M.B.A. Program at Pennsylvania State University. Formerly, he was Chairman and Chief Executive Officer of VivoQuest, a private biopharmaceutical company. From 1994 until June 2001, Mr. Tombros served as President and Chief Executive Officer of Enzon Pharmaceuticals, Inc., a publicly held biopharmaceutical company. Prior to joining Enzon, Mr. Tombros spent 25 years with Pfizer Inc., a global healthcare company in a variety of senior management positions including Vice President of Marketing, Senior Vice President and General Manager of the Roerig Pharmaceuticals Division, Executive Vice President of Pfizer Pharmaceuticals Division, Director of Pfizer Pharmaceuticals Division, Vice President of Corporate Strategic Planning, and Vice President, Corporate Officer, Pfizer Inc. Mr. Tombros is Chairman of PharmaNet Development Group, Inc. and is a Board Director at Cambrex and Protalex, all publicly held life science companies. Peter Tombros earned B.S. and M.S. degrees from Pennsylvania State University and an M.B.A. degree from the University of Pennsylvania Wharton Graduate School of Business.

Organization Position Status
NPS Pharmaceuticals, Inc. Chairman Current
PharmaNet Inc. Chairman of the Board Current
Alpharma, Inc. Chairman Current
Investigative Management Group Board of Directors Current
Pharmanet Development Group, Inc. Board of Directors Current
Protalex, Inc. Board of Directors Current
Icoria Inc. Board of Directors Current
NPS Pharmaceuticals, Inc. Director Current
Dendrite International, Inc. Director Current
Cambrex Corporation Board of Directors Current
Enzon Pharmaceuticals, Inc. Chief Executive Officer Former
Enzon Pharmaceuticals, Inc. President Former
Pfizer Inc. Senior Vice President Former
Pfizer Inc. Vice President of Marketing Former
Pfizer Inc. General Manager Former
NPS Pharmaceuticals, Inc. Lead Director Former
The Pennsylvania State University Executive In Residence Former
Pfizer Inc. Corporate Officer Former
New Jersey Technology Council Chairman Former
Enzon Pharmaceuticals, Inc. Director Former
Wharton Graduate School of the University of Pennsylvania MBA Former
The Pennsylvania State University M.S. Former
Penn State MS Degrees Former
Penn State BS Former
The Pennsylvania State University B.S. Former

Organization Position Status
Alpharma, Inc. Chairman, Compensation Committee Current
Alpharma, Inc. Board of Directors Former

Organization Position Status
Financial Security Assurance, Inc. Co-Founder Current
Global Payments, Inc. Lead Director Current
Investment Technology Group, Inc. Audit Committee Chairman Current
Alpharma, Inc. Audit & Corporate Governance Committee Chairman Current
Asset Acceptance Capital Corp. Board of Directors Current
Global Payments, Inc. Board Director Current
Integration Technologies Group Director Current
123Jump.com Board of Directors Current
The New Power Chief Financial Officer Former
Financial Security Assurance, Inc. Coo Former
Global Payments, Inc. Chief Operating Officer Former
Financial Security Assurance, Inc. Executive Vice President Former
MasterCard International, Inc. Senior Executive Vice President Former
The New Power Managing Director Former
The New Power Finance and Operations Experience Former
Global Resources Ltd. Former
Alpharma, Inc. Board of Directors Former
Investment Technology Group, Inc. Board of Directors Former
Financial Security Assurance, Inc. Board Director Former
American University Law Degree Former
American University Bachelor of Arts Former
American University Degree Former

Organization Position Status
Alpharma, Inc. Board of Directors Current

Organization Position Status
Alpharma, Inc. Board of Directors Current
Alpharma, Inc. Chairman Former

Organization Position Status
Sunett Board of Directors Current
Connect Celanese Board of Directors Current
Celanese Corporation Board of Directors Current
At Plastics Inc Board of Directors Current
Sorbates Board of Directors Current
PolyOne Corporation Board of Directors Current
Alpharma, Inc. Director Current
Vinamul Polymers Board of Directors Current
Celanese Chemicals, Inc. Board of Directors Current
Premiol Board of Directors Current
Sunett Member Current
University Hospitals Health System, Inc. Chief Executive Officer Former
University Hospitals Health System, Inc. President Former

Organization Position Status
Alpharma, Inc. Board of Directors Current

Organization Position Status
Alpharma, Inc. Board of Directors Current
advertisement
IndustryTop Rated
advertisement